Vaccine is already being given to high-risk people in the United States and Britain
TUESDAY, Dec. 22, 2020 (HealthDay News) — The Pfizer COVID-19 vaccine was approved by the European Union (EU) on Monday and should soon be available in all 27 member nations.
Deliveries of the vaccine are expected to begin this weekend, with shots beginning across the EU between Dec. 27 and 29, the Associated Press reported.
“As we have promised, this vaccine will be available for all EU countries at the same time, on the same conditions,” said EU President Ursula von der Leyen. “This is a very good way to end this difficult year, and to finally start turning the page on COVID-19.”
The vaccine is already being given to high-risk people in the United States and Britain, the AP reported.
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Parts of the World Seeing New COVID-19 Variant 
HHS, NIH Unveil Vaccine Initiative to Protect Against Future Pandemics 
Hospital-Onset SARS-CoV-2 Infection During Omicron Linked to Morbidity 
Staffing, Scheduling, and Wage Changes Could Reattract Nurses Back to Hospitals 
Skilled Nursing Facility Capacity Declined Between 2019 and 2024 
Physical Design of Critical Care Units Influences Nursing Culture 
Low Capability Pediatric Hospitals More Than Doubled From 2003 to 2022 
